Immune therapy scores big win against lung cancer in study
CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common forms of the disease.
One study found using one of these drugs — Merck's Keytruda (kee-TROO-dah) — with usual chemotherapy greatly improved survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs.
That's a first, and it's expected to quickly set a new standard of care for about 70,000 patients each year in the United States.
Trending Health News... read more
- 11:42 Trump: New Air Force One to get red, white and blue makeover
- 08:20 The Latest: Trump defends Putin summit, vows 'big results'
- 06:45 Democrat Kim Olson has more cash, less debt than Agriculture...
- 06:45 Texas Senate panel meets today to discuss mass shootings in schools
- 05:05 Ex-FBI chief Comey urges voters to support Democrats in fall
- 04:34 Trump backs off siding with Russia over US intelligence
- 00:41 Trump backs off siding with Russia over US intelligence
- 22:13 Where Texas politicians stand on marijuana